BofA downgraded Oscar Health to Neutral from Buy with a price target of $21, down from $25. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on OSCR: Oscar Health price target raised to $25 from $22 at BofA Oscar Health price target raised to $24 from $20 at Wells Fargo Oscar Health reports Q1 EPS 62c, consensus 27c Largest borrow rate increases among liquid names Disclaimer & DisclosureReport an Issue
